Anti-Cancer Immune Priming with Beta-Radioligand Therapy and Isoform-Selective Targeting of 4Ig-B7-H3
Sarah E. Glazer, Margie Nicole Sutton, Ping Yang, Federica Pisaneschi, Manu M. Sebastian, Seth T. Gammon, David Piwnica-Worms
This paper develops a monoclonal antibody targeting 4Ig-B7-H3 for beta-radioligand therapy, showing improved tumor-specific binding and immune priming effects in preclinical models.
Theranostics · Mar 12, 2026Peer-reviewedCancer Biology